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Large clinical trials (l-4) evaluating the benefit of throm- 
bolytic agents in patients with acute rnyocardiai infarction 
have generally shown that atients treated soon after the 
onset of chest pain have a greater diction in mortality than 
do patients treated later. For ex 
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01990 by the American College of Cardiology 
ISSB) (1) placebo-controlled trial of stre~to~~~ase resulted 
ia an 18% overall reduction in mortality in patients treated 
within 12 h of the onset of symptoms: however, monlality 
was reduced by 47% in the subset receiving treatment within 
the first hour of symptoms. Unfortunately, because of delays 
associated with patient recognition of the need for medical 
attention, transport times and delays after hospital admis- 
sion, few patielnts are currently treated d 
of reducing the time to 
e initiation of thera 
Few studies have evaluated the be~c~t of early trea 
of acute myocdrdial ~~farctjo~ by prehos 
er, even in the ~rct~ro ytic era, some data 
ed that paramedic trea t of secofldary corn~~~ca- 
tions of acute infarction results in i 
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come. Resuscitation of patients who develop ventricular 
fibrillation and cardiac arrest is an obvious example. In 
addition, prehospital treatment of pulmonary edema, hypo- 
tension and hypoxemia by the use of diuretic drugs, oxygen, 
intubation and vasopressors may also reduce mortality (6). 
In the first study (9) of prehospita! administration of 
thrombolytic therapy, physicians made the diagnosis and 
began treatment in the patient’s home. In the United States, 
out of hospital emergency care is primarily delivered by 
paramedics operating under remote physician direction. In 
most cases, paramedics evaluate patients with chest pain 
n those with possible serious disorders for 
fhrther hospital evaluation and treatment. If patients are to 
receive thrombolytic therapy before hospital arrival, it mast 
be demonstrated that paramedics can select appropriate 
patients and pro!~ly initiate thrombolytic therapy. It must 
also be shown that such a strategy contributes to a mean- 
in&A reduction in the delay until treatment, is safe and 
reduces the extent and complications of myocardia! infarc- 
tion. This report describes the findings in 2,472 patients with 
chest pain of presumed cardiac origin who were evaluated by 
paramedics for consideration of prehospital initiation of 
thrombolytic therapy. 
The Myocardid Infarction Triage and 
Project is a two phase study to eva!uatc 
prehospital administration by paramedics of thrombolytic 
therapy to patients with acute myocardial infarction. Phase 
I, described here, was designed to determine the feasibility 
of medic selection of ~~prop~~te patients and to esti- 
mate the possible time saving of such an intervention. Phase 
II (begun in November 1988) is a randomized controlled 
clinical trial that will compare prehospital and hospital 
initiation of thrombolytie therapy using aspirin and recom- 
tissue-type plasminoBcn activator (Alteplaae). 
project involves aN I9 hospitals andfive paramedic 
systems operati,rs in the city of Sea 
King Counry--an area of >2 
ion of 1.8 million people. 
mmated telephone calls to 911, 15 paramedic-staffed ambu- 
lances operate in this area and work under the authority of 
physicians located in eight base station hospitals. Paramed- 
ics first obtain a directed history and physical examination, 
then acquire an electrocardiogram (ECG) to a 
ban station 
Candidates for thmbolytic therapy. The findings are then 
by telephone or radio with this physician, who 
s whether the patient meets a!! the criteria for 
consideration of prehospital-initiated thrombolytic treat- 
ment. AU treatments delivered by paramedics, beyond initial 
steps in the management of cardiac arrest or hemorrhagic 
shock, are administered according to t e verbal prescription 
of physician. 
lent caption. For t yo~a~dja~ I~farct~~~ 
and Intervention Project, a: prehospita! medical 
form was modified to include a ~heck!ist containing 
and physical examination inclusion and exclusion 
that would help select those who might be the most 
appropriate candidates fo transmission and further 
consideration for thrombolytic rapy. Possib!e candidates 
for a prehospital ECC were 
were alert, oriented and 11 
suspected cardiac origin for hi5 min and 6 
selection criteria included 
< 180 mm Hg, diastolic p 
blood pressure difference between 
minimize the possibility of aorti 
excluded for any known bleed 
stroke, seizures or tmnsicnt ccreb 
surgery in the preceding 2 month 
in the past year, cancer or other c 
disease or jaundice, renal insuffi~i~~~~ or ins~~i~~depende~t 
diabetes, a history of active c 
line placement and warfarin t 
were met was a standard I2 le 
its. These strict criteria were selected to identify those 
patients who were likely to benefit most and to be at least 
risk For complications of prehospitall initiation of tbrom- 
bolytic thempy. 
Ali ~~ti~~ts with ehma paim o esumed cardiac origin 
who had been screened by pam s using this checklist 
were subsequently follo 
those admitted were rev; 
noses, treatments delivere 
phase of the project, in which 
prehospital treatment were id ermitted us to eval- 
uate the accuracy of case se ton and the possible time 
computer-interpreted record to be printed by a strip chart 
recorder for pammedics. The electrocardiograph is coupled 
to a cellular telephone. After printing of the ECG at the site, 
the telephone is automatically dialed and the digitized ECC 
is sent to a receiving unit that prints a standard-sized record 
for the base station physician. This transmitted ECG has 
been shown to accurately reproduce the initial record (IO). 
The ECG was deemed indicative of acute epicardia! injury if 
two or more contiguous leads in a group location displayed 
ST segment elevation 4 mm. Patients with this finding were 
considered potential candidates for treatment. 
wsmnent. The hospital records of a!! patients 
admitted to the hospital were abstracted and the discharge 
diagnoses and treatments delivered were tabulated. Ninety- 
nine percent of records were abstracted. Because enzyme 
Alert, oriented. could cooperate 
Stroke. seizures, olbsr L9raia disorders 
Neccnt ~~~stro~~~testili~9~ bleedisg 
Raccnt surgery 
*Includes patiemts taking warfarin or insulin and those with active 
hepatitis. jaundice. trauma, history of colitis or renal failure. BP = blood 
1 = myocardial infarction. 
six percent were alert an 
an adequate history of their illness. Sixty-seven p rcent of 
these patients were ~75 years of age and 83% had pain 
persisting for at least 15 min and <6 h when first een by 
paramedics. Patients were excluded from further consider- 
ation, including ~rehos~ita~ ECGs, if they had one or more of 
the following conditions: rofsund by~otemsio~ (systolic 
blood pressure <80 mm in 2%; hypertension 
or diastohc blood 
; a difference of 2220 
systolic blood pressure between left a d right arms in It% 
(only 1 of 281 with this finding had aortic dissection diag- 
nosed in hospital); a history of stroke or other central 
nervous system disorders in 12%; recent surgery in 6% and 
Prehosgital Patients 
With Acute 
infarction 
ST elevation 105 (64%) 
Primary ST depression 21 (13%) 
Other nonspecific ST changes 29 (18%) 
Other abnormalities 8 (5%) 
ysician evaluation. 
le because of early 
on is §~ccess~~~ 92% of 
and left ventricular hy~ertro~b~. Thus, 4% of the 2,47; 
s seen by paramedics because of 
et each of the clinical selection cr 
ent by paramedics in a future phase o
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No EC0 otitwla 
tion 81 teatial tlme saving of ~~~~~i 
ment, Most patients identified as suitable candidates for 
prehospital initiation of thrombolytic therapy called 911 
within the first hour after onset of symptoms (Fig. 2). The 
average time (2 SD) from the onset of chest pain to calling 
911 was 48 k 57 min (median 25). Response time for 
paramedics after the 91 I dispatch averaged 8 -e 4 min. The 
time required to locate the patient, complete the history and 
physical examination, obtain an ECG and discuss the find- 
x and whislw plots of the time from onset of chest pain 
tion of each step of the cval~~tio~~ and time 
leuths from the median). 
ings with the ~bysic~~~ 
Figure 1. Effect of various possibIe 
clinical and eIect~cardiog~~hic (WC) 
selection criteria on the: propo~~oo of 
eligible patients with acute myoca 
infarction (Map fur cons~de~t~on for 
prehospital thrombolytic therapy. Al- 
tering the blood pressure, age and time 
with ST elevation and depression 
rmit tl~atnlent in about 35% 
Each of the criteria used by paramed- 
ics to select patients for the 
Iilfarc Triage and Iflte~vcnt~~~ 
itics ure shown to derno~~st~~t 
itself addsd 7 min to the eval~tioa time. T 
acquisitive and trans 
approximately 30 s. 
treatment initiated 
hospital arrival (Fig. 2). The total time from chest pain onset 
to initiation of hospital t~atment for preh0spita.l eligible 
patients was 144 ts 63 min or 73 % 44 min (median 62) later 
than what might have been possible, on average, in the 
prehospital setting (Fig. 3). 
0s Ike 290 other patients who also had a diagnosis oj 
acute myocardiai irlfarctiorl bat failed to meet the strict 
~rehospjta~ criteria, 96 (34%) received thrombolytic therapy 
(n = 7.5) or emergent angioplasty (n = 281, or both, after 
further evaluation in the hospital. Reasons for prehospital 
exclusion of these subsequently treated patients (some pa- 
tients had more than one exclusion) included the fo 
prehospital evidence of profound hypotension in 14 and 
hypertension in IS; a >20 mm Hg difference in blood 
pressure arm cuff readings in 12 (none o these patients had 
aortic dissection); pain for >6 h in 6; a istory of stroke or 
bleeding problems in 11; age ~74 years in 15 and miscella- 
neous reasons in 6. In addition, 26 patients met all of the 
wed with acr1tal hos~~j~at 
e median time fwm chest 
physicians. The median time until initiation of treatment for ex- 
cluded patients was 2 h and 20 min. 
be initial ~ublis~~ed report (9) of pre 
mbo~ytic therapy by physicians in 
n patients were treated within I.5 
symptoms, there was a 9% u s improvement in left ven- 
tricular ejection fraction co red with the result when 
therapy was initiated later. T ieve these early treatment 
times, emergency physicians responding in ambulances ob- 
tained a standard ECC and initiated thrombolytic therapy in 
the patient’s home. Similar ~e~imi~ary reports (11-W slap- 
E~zergenry medical services in th 
considerably from those in muny other countries. 
programs in this country are organized as paramedic4 
systems that operate under the guidance of a physician at a 
e easily tra~sferrab~e 
ical systems. 
providing pain relief and other treatment if needed and 
transport times-are unalterable. The cb~c~list, in fact, 
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provides a more consistent and complete assessment of 
patients. We obtained an ECG only in those patients who 
met the clinical checklist criteria. The use of the device in 
patients :uith other illnesses would, at least for the present, 
serve little useful purpose and potentially delay hospital 
transport and treatment. In addition, the acquisition of an 
ECG in unselected patients greatly increases the possibility 
of inappropriate selection ofi dtients to receive thrombolysis 
(19). In those who met each of these checklist history and 
examination criteria, ST segment elevation is likely to be 
truly representative of acute coronary thrombosis. 
t~ntment, Qnly 27% of 
all patients with pres chest pain met RII of the 
strict histor examination criteria and thus received a 
prehospital Of those, only one in five showed ST 
ent elevation. Tak 
ude that the props 
with chest pain who would be eligible for thrombolytic 
is very small, The paramedics, like the emergency 
ent, screen many more patients who have chest pain 
ients who have evidence of acute infarction. With 
this in mind, the true potential use of early treatment is best 
extrapolated from the subset of patients with acute myocar- 
dial infarction. Of these, 23% would have been eligible 
candidates and selected for prehospital treatment by these 
conservative criteria. Another 21% of patients with acute 
infarction who had been excluded in the prehospital setting 
were later treated with thrombolytic therapy after further 
hospital evaluation of possible risk factors. Perhaps in the 
future, as these prehospitnl selection criteria are extended, 
most of these latter patients could be safely prescribed 
thrombolytic therapy in the prehospital setting. 
If is s!ri&ng that porentid prehospitd trmtnwnr cnntii- 
cicltes often sought medkal atrsntion in ~~~~r~~~~~~l minufes 
after the otw ~~~y~~~~~~. In fact, if thrombolytic therapy 
been available, treatment could have &en initia 
of patients within the first hour instead of in the 
ients observed. However, the true time saving with 
hospital initiation of treatment can be accurately assessed 
in a randomized trial. In this tvaluation of potential 
time saving with such a strategy, treatment was 
tale3 min (med/an) afier the prehospital di 
est benefit seemed ;o be associated with 
d+Says after hospital arrival. Perbnps hospital delays will 
dimir+h as more rapid treatment is emphasized and prehos- 
Pital ~lectr~ardio~~ph~ becomes routine. However, in our 
own hospitals, which have been invo!ved in tbrombslytic 
trials for St%p%l yean, I\ 1 h delay is typical and reflects the 
many administ~tive, sc~e~i~~, di nostic and physician 
Praeti%S and other logistic impediments to rapid 
ent (20,211. 
A simple checklist and protocol for the 
evaiuation Of patients with chest pain combined with a new 
technology were used by paramedics and a remote station- 
JACC Vol. 15. No. 5 
April 1990~925-31 
based physician to select the majority of patients with early 
evidence of acute myocardid infarction for tre 
thrombolytic therapy within the first hour of sy 
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